{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-072444","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.449000+00:00","generated_at":"2026-06-25T00:52:59.591049+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"First Wave BioPharma director Gregory Oakes resigns; board lowers quorum to one-third","bullets":["Gregory Oakes resigned from the Board effective June 16, 2022; no disagreement cited.","Board amended bylaws to reduce stockholder meeting quorum from majority to one-third of voting power.","Company filed Certificate of Correction clarifying Board's right to designate preferred stock series with/without voting powers, effective retroactively to July 13, 2016.","Exhibits 3.1 (bylaw amendment) and 3.2 (Certificate of Correction) filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-072444","json":"https://secwatch.observer/filing/0001104659-22-072444.json","markdown":"https://secwatch.observer/filing/0001104659-22-072444.md","text":"https://secwatch.observer/filing/0001104659-22-072444.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922072444/0001104659-22-072444-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922072444/tm2218808d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:52:59.591049+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d46bbcd05e","claim":"Gregory Oakes resigned as Director at GridAI Technologies Corp..","evidence_excerpt":"On June 16, 2022, Gregory Oakes submitted his resignation from the Board of Directors (the “Board”) of First Wave BioPharma, Inc. (the “Company”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922072444/0001104659-22-072444-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}